Pardes Biosciences Inc. (PRDS)
2.18
0.02 (0.93%)
Aug 30, 2023, 7:59 PM - Market open
0.93% (1D)
| Bid | n/a |
| Market Cap | 135.19M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -96.28M |
| EPS (ttm) | -1.28 |
| PE Ratio (ttm) | -1.703125 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | n/a |
| Volume | 2,150,077 |
| Avg. Volume (20D) | 509,687 |
| Open | 2.16 |
| Previous Close | 2.16 |
| Day's Range | 2.13 - 2.18 |
| 52-Week Range | 0.75 - 3.67 |
| Beta | 0.42 |
About PRDS
Pardes Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics to improve the lives of patients suffering from life-threatening disease. Its lead candidate is the PBI-0451 that is in clinical development stage to treat and prevent severe acute respiratory syndrome coronavirus 2 infections and associated diseases. The company was incorporated in 2020 and is headquart...
Industry Biotechnology
Sector Healthcare
IPO Date Dec 27, 2021
Employees 57
Stock Exchange NASDAQ
Ticker Symbol PRDS
Website https://www.pardesbio.com